LANCE BERBERIAN - 11 Feb 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, CIO & CTO
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Lance Berberian
Issuer symbol
LH
Transactions as of
11 Feb 2023
Net transactions value
-$21,091
Form type
4
Filing time
14 Feb 2023, 14:01:56 UTC
Previous filing
09 Feb 2023
Next filing
03 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +290 +1.5% 20,253 11 Feb 2023 Direct F1
transaction LH Common Stock Tax liability $21,091 -85 -0.42% $248.13 20,168 13 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -290 -14% $0.000000 1,827 11 Feb 2023 Common Stock 290 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.
F4 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.